MDD
Jun 24, 2022
Will a Robust Pipeline Address the Major Depressive Disorder Treatment Conundrum?
In the contemporary world, major depressive disorder (MDD) is one of the diseases responsible for the greatest healthcare burden. In the United States, more than 24 million people suffer from major depressive disorder each year, while in Europe, about 20 million are diagnosed with the major depressive disorder each...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
